Final results of a phase I/II dose escalation trial of valtorcitabine in patients with chronic hepatitis B

被引:0
作者
Lim, SG
Lai, CL
Myers, M
Yuen, MF
Wai, CT
Lloyd, D
Pietropaolo, K
Zhou, XJ
Chao, G
Brown, NA
机构
[1] Natl Univ Singapore Hosp, Dept Med, Singapore, Singapore
[2] Univ Hong Kong, Univ Dept Med, Hong Kong, Hong Kong, Peoples R China
[3] Idenix Pharmaceut, Cambridge, MA USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:16 / 16
页数:1
相关论文
empty
未找到相关数据